Subthalamic nucleus local field potential stability in patients with Parkinson's disease

Neurobiol Dis. 2024 Sep:199:106589. doi: 10.1016/j.nbd.2024.106589. Epub 2024 Jul 3.

Abstract

Background: Despite the large body of work on local field potentials (LFPs), a measure of oscillatory activity in patients with Parkinson's disease (PD), the longitudinal evolution of LFPs is less explored.

Objective: To determine LFP fluctuations collected in clinical settings in patients with PD and STN deep brain stimulation (DBS).

Methods: Twenty-two STN-DBS patients (age: 67.6 ± 8.3 years; 9 females; disease duration: 10.3 ± 4.5 years) completed bilateral LFP recordings over three visits in the OFF-stimulation setting. Peak and band power measures were calculated from each recording.

Results: After bilateral LFP recordings, at least one peak was detected in 18 (81.8%), 20 (90.9%), and 22 (100%) patients at visit 1, 2, and 3, respectively. No significant differences were seen in primary peak amplitude (F = 2.91, p = 0.060) over time. Amplitude of the second largest peak (F = 5.49, p = 0.006) and low-beta (F = 6.89, p = 0.002), high-beta (F = 13.23, p < 0.001), and gamma (F = 12.71, p < 0.001) band power demonstrated a significant effect of time. Post hoc comparisons determined low-beta power (Visit 1-Visit 2: t = 3.59, p = 0.002; Visit 1-Visit 3: t = 2.61, p = 0.031), high-beta (Visit 1-Visit 2: t = 4.64, p < 0.001; Visit 1-Visit 3: t = 4.23, p < 0.001) and gamma band power (Visit 1-Visit 2: t = 4.65, p < 0.001; Visit 1-Visit 3: t = 4.00, p < 0.001) were significantly increased from visit 1 recordings to both follow-up visits.

Conclusion: Our results provide substantial evidence that LFP can reliably be detected across multiple real-world clinical visits in patients with STN-DBS for PD. Moreover, it provides insights on the evolution of these LFPs.

Keywords: Deep brain stimulation; Local field potentials; Parkinson's disease.

MeSH terms

  • Aged
  • Deep Brain Stimulation* / methods
  • Female
  • Humans
  • Male
  • Middle Aged
  • Parkinson Disease* / physiopathology
  • Parkinson Disease* / therapy
  • Subthalamic Nucleus* / physiopathology